skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

About Pamela

USA

+9 year(s) experience

Pamela Spicer |Pharma Intelligence|
As an Analyst with Trialtrove, Pamela Spicer develops and manages clinical trials content. She covers the autoimmune/inflammation, CNS, and ophthalmology therapeutic areas.

Analyst Articles

  • Pink Sheet: 世界の薬事規制と承認審査に関するニュース

    Webinar: FDA and its Commissioners

    By nielsen-hobbs 05 Nov 2019

    The US FDA has experienced an extended period with an acting commissioner. However, the agency continues to achieve its user fee dates, and hardly appears rudderless. Still, having a confirmed commissioner will give FDA more stability and power. But with application review looking to become more efficient and flexible, what could a new commissioner do to change the relationship between industry and FDA?

    Topic fda

  • Pink Sheet: 世界の薬事規制と承認審査に関するニュース

    US FDA To Withdraw Pain Drug Guidance As Part Of Response To Opioid Epidemic

    By nielsen-hobbs 30 Aug 2018

    US FDA To Withdraw Pain Drug Guidance As Part Of Response To Opioid Epidemic

    "At least four" guidances will replace it, Commissioner Gottlieb notes in frank update which states "I don’t want to look back ten years from now and wish there were more policies we had pursued, or more steps we had taken, to stop the advance of this crisis."

    Topic fda